← Back to patent-cliff list
Oral Arsenic Trioxide (Rasayani Biologics)
Tier C — Watch / tradeOral Arsenic Trioxide (Rasayani Biologics)
Rasayani Biologics Pvt Ltd
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：TrxR
Indications (approved)：Acute promyelocytic leukaemia, Solid tumour, Haematological malignancy
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Oral Arsenic Trioxide (Rasayani Biologics)?
Approved indications include: Acute promyelocytic leukaemia, Solid tumour, Haematological malignancy.
When does the Oral Arsenic Trioxide (Rasayani Biologics) patent expire?
No public expiry year is available for Oral Arsenic Trioxide (Rasayani Biologics) yet; this page updates once verified.
How do I get a quote for Oral Arsenic Trioxide (Rasayani Biologics) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-02